PUBLIC COMPANY
saveCYCLE
USupdated 3mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- J&J pays Sail $785M, charting course to possible in vivo CAR-T buyoutJohnson & Johnson is cruising deeper into in vivo CAR-T waters, paying $785 million upfront to strike a deal that gives it the option to acquire Sail Biomedicines.fiercebiotech · 2d ago
- Researchers concerned by underutilization of accelerated approval in oncologyMost adult cancer drugs approved by the US Food and Drug Administration (FDA) over the past two decades were regular approvals for expanded indications based on surrogate endpoints, rather than acc…raps · 2d ago
- Recon: FDA adcomm votes against Capricor’s DMD drug; Cytokinetics gets UK approval, NICE backing for heart drugWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 2d ago
- FDA updates product-specific guidelines for injectable peptidesThe US Food and Drug Administration (FDA) has updated 17 draft product-specific guidances (PSGs) to assist sponsors in submitting abbreviated new drug applications (ANDAs) for injectable peptide pr…raps · 2d ago
- FDA unveils FY 2027 user fee ratesThe US Food and Drug Administration (FDA) has published its user fee rates for FY 2027 across its prescription drug, generic drug, biosimilar, medical device, and over-the-counter drug programs. Th…raps · 2d ago
- Euro Roundup: EFPIA pushes for shorter trial approval times in EU Biotech ActEFPIA has called for lawmakers to go beyond the reductions in clinical trial approval times proposed in the Biotech Act.raps · 2d ago
- GSK cost-cutting plan includes global layoffsFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 2d ago
- After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenGrowing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence and low diagnosis.stat · 4d ago
- From confidence to capital: Positioning biotech for the next growth cycleHow can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.biopharma_dive · 5d ago
- Opinion: My husband’s suicide shows there’s something very wrong with the U.S. insurance industry“My love for Randy and my professional experience were not enough to save him,” a physician writes about her husband’s suicide.stat · 12d ago
comments(0)
5-min edit window · permanent after that